Tue, October 10, 2017
Mon, October 9, 2017
Fri, October 6, 2017
Thu, October 5, 2017
Wed, October 4, 2017
Tue, October 3, 2017
Mon, October 2, 2017
Fri, September 29, 2017
Thu, September 28, 2017
Wed, September 27, 2017
Tue, September 26, 2017
Mon, September 25, 2017
Fri, September 22, 2017
Thu, September 21, 2017
Wed, September 20, 2017
Tue, September 19, 2017
Mon, September 18, 2017
Fri, September 15, 2017

Alethia Young Maintained (AMGN) at Buy with Increased Target to $186 on, Sep 29th, 2017


//stocks-investing.news-articles.net/content/201 .. th-increased-target-to-186-on-sep-29th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Alethia Young of Credit Suisse, Maintained "Amgen Inc." (AMGN) at Buy with Increased Target from $177 to $186 on, Sep 29th, 2017.

Alethia has made no other calls on AMGN in the last 4 months.



There are 6 other peers that have a rating on AMGN. Out of the 6 peers that are also analyzing AMGN, 4 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Yee of "RBC Capital" Initiated at Hold and Held Target at $192 on, Friday, September 15th, 2017
  • Ian Somaiya of "BMO Capital" Downgraded from Buy to Hold on, Wednesday, July 26th, 2017
  • Carter Gould of "UBS" Maintained at Hold with Increased Target to $185 on, Wednesday, July 26th, 2017
  • Andrew Peters of "Deutsche Bank" Initiated at Hold and Held Target at $172 on, Friday, June 23rd, 2017


These are the ratings of the 2 analyists that currently disagree with Alethia


  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $195 on, Thursday, July 27th, 2017
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $189 on, Monday, July 10th, 2017

Publication Contributing Sources